fleroxacin and trimethoprim, sulfamethoxazole drug combination

fleroxacin has been researched along with trimethoprim, sulfamethoxazole drug combination in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agoki, E; D'Costa, LJ; Ndinya-Achola, JO; Ombette, J; Plourde, PJ; Plummer, FA; Ronald, AR; Slaney, LA1
Altwegg, M; Hohl, P; Lüthy-Hottenstein, J; Zollinger-Iten, J1
Hohl, P; Kafader, FM; Salfinger, M1
Cullmann, W; Dechène, M; Stieglitz, M1
Arman, D; Tural, D; Willke, A1

Trials

1 trial(s) available for fleroxacin and trimethoprim, sulfamethoxazole drug combination

ArticleYear
A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid.
    The Journal of infectious diseases, 1992, Volume: 165, Issue:5

    Topics: Administration, Oral; Adult; Chancroid; Double-Blind Method; Fleroxacin; Follow-Up Studies; Humans; Male; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination

1992

Other Studies

4 other study(ies) available for fleroxacin and trimethoprim, sulfamethoxazole drug combination

ArticleYear
In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Fleroxacin; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination

1990
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1987
[Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
    Immunitat und Infektion, 1988, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Humans; Mutation; Ofloxacin; Serratia marcescens; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1988
In vitro activity of eight antibiotics against Salmonella and Shigella species.
    European journal of epidemiology, 1994, Volume: 10, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination

1994